The role of FDG PET in the clinical management of head and neck cancer
- 1 November 1998
- journal article
- review article
- Published by Elsevier in Oral Oncology
- Vol. 34 (6) , 466-471
- https://doi.org/10.1016/s1368-8375(98)00050-5
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Detection of unknown primary head and neck tumors by positron emission tomographyInternational Journal of Oral & Maxillofacial Surgery, 1997
- Occult primary tumors of the head and neck: detection with 2-[F-18] fluoro-2-deoxy-D-glucose SPECT.Radiology, 1996
- Preoperative identification of benign versus malignant parotid masses: A comparative study including positron emission tomographyThe Laryngoscope, 1995
- Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction.Radiology, 1993
- [18F]Fluorodeoxyglucose Uptake in TumorsJournal of Computer Assisted Tomography, 1993
- Over-expression of facilitative glucose transporter genes in human cancerBiochemical and Biophysical Research Communications, 1990
- Florodeoxyglucose imaging: A method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumorsCancer, 1988
- THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT1Journal of Neurochemistry, 1977
- Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tractsCancer, 1972
- On the Origin of Cancer CellsScience, 1956